8-K
filed June 1, 2026, 8:30 AM ET
ticker ADTX
CIK 0001726711
leadership
confidence high
sentiment neutral
materiality 0.80
Aditxt names Jeffrey M. Busch Interim CEO; Amro Albanna steps down
Aditxt, Inc.
- Amro Albanna resigned as CEO and director effective May 31, 2026; Rowena Albanna resigned as COO effective June 5, 2026.
- Jeffrey M. Busch appointed Interim CEO effective May 31, 2026; also continues as CEO of Ignite Proteomics subsidiary.
- Busch previously founded and led Global Medical REIT (NYSE: GMRE) to $1B enterprise value with ~8.5% avg dividend yield.
- Brian Brady appointed non-executive Chairman of the Board effective May 31, 2026.
- Shahrokh Shabahang resigned from Board but remains Chief Innovation Officer; departures not due to disagreements.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Amro Albanna resigned as Chief Executive Officer at Aditxt, Inc..
- Action
- resigned
- Role
- Chief Executive Officer
Exact text from the filing
On May 29, 2026, Amro Albanna notified the Company of his decision to resign as Chief Executive Officer of Aditxt, Inc. (the “Company”), and on May 30, 2026, Mr. Albanna resigned as a member of the Company’s Board of Directors (the “Board”), effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Rowena Albanna resigned as Chief Operating Officer at Aditxt, Inc..
- Action
- resigned
- Role
- Chief Operating Officer
Exact text from the filing
On May 31, 2026, Rowena Albanna notified the Company of her decision to resign as Chief Operating Officer of the Company, effective June 5, 2026.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Amro Albanna resigned as Director at Aditxt, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On May 29, 2026, Amro Albanna notified the Company of his decision to resign as Chief Executive Officer of Aditxt, Inc. (the “Company”), and on May 30, 2026, Mr. Albanna resigned as a member of the Company’s Board of Directors (the “Board”), effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Brian Brady was appointed as Chairman of the Board at Aditxt, Inc..
- Action
- appointed
- Role
- Chairman of the Board
Exact text from the filing
On May 31, 2026, the Board appointed Brian Brady, an independent director of the Company, to serve as non-executive Chairman of the Board, effective as of such date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Shahrokh Shabahang resigned as Director at Aditxt, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On May 31, 2026, Shahrokh Shabahang resigned as a member of the Board, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Jeffrey M. Busch was appointed as Interim Chief Executive Officer at Aditxt, Inc..
- Action
- appointed
- Role
- Interim Chief Executive Officer
Exact text from the filing
On May 31, 2026, the Board appointed Jeffrey M. Busch, age 68, to serve as Interim Chief Executive Officer of the Company, effective as of such date.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.